Showing results (211-220 of 452) with videos related to

Sort By:
Pageof 46
Annals of the New York Academy of Sciences|June 25, 2021
Comparing costs and cost-efficiency of platforms for micronutrient powder (MNP) delivery to children in rural UgandaWhitney Schott, Belinda Richardson, Emily Baker, et al.
BMJ Open|March 27, 2025
Diet therapy (The 8×5 Diet) for adults living with bile acid diarrhoea: protocol for a feasibility randomised controlled trialYvonne A McKenzie, Lawrence Kelman, Michelle O'Connor, et al.
Current Medical Research and Opinion|April 30, 2020
Health utility estimation in children and adolescents: a review of health technology assessmentsGaëlle Bégo-Le Bagousse, Xiaoying Jia, Sorrel Wolowacz, et al.
Plos One|May 18, 2018
Correction: Using the Normalization Process Theory to qualitatively explore sense-making in implementation of the Enhanced Recovery After Surgery programme: "It's not rocket science"Eileen Sutton, Georgia Herbert, Sorrel Burden, et al.
Bone Marrow Transplantation|August 1, 1992
Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 childrenV Méresse, O Hartmann, G Vassal, et al.
Clinical Nephrology|March 1, 1984
Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patientsE Benhamou, A M Courouce, P Jungers, et al.
Bone Marrow Transplantation|July 1, 2008
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimenA Cacchione, A LeMaitre, D Valteau Couanet, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 25, 2025
Hypercalcemia in patients with type 2 intestinal failure receiving parenteral support: A descriptive cohort studyMaja Kopczynska, Thaksala Uduvawidana, Simon Harrison, et al.
European Journal of Clinical Nutrition|March 23, 2025
A systematic review of the impact of Elexacaftor/Tezacaftor/Ivacaftor on body composition in people with cystic fibrosisLaura Kinsey, Hannah Winterbottom, Lydia Hudson, et al.
Pharmacoeconomics|September 25, 2007
Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UKSorrel E Wolowacz, Neil Roskell, Steven Kelly, et al.
Pageof 46